Press releases

Month Year

Email alerts

Jan 16, 2018

Medtronic Receives FDA Clearance for Riptide(TM) Aspiration System

New System Expands Neurovascular Product Portfolio for the Treatment of Acute Ischemic Stroke

DUBLIN - January 16, 2018 - Medtronic plc (NYSE:MDT) today announced that the company's Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM)...
Jan 11, 2018

New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity

Therapy Delivered via the Medtronic SynchroMed(TM) II Infusion System

DUBLIN - January 11, 2018 - Medtronic plc (NYSE:MDT) today announced the publication of results from the 'Spasticity In Stroke-Randomised Study' (SISTERS) trial in the Journal of Neurology,...
Jan 10, 2018

FDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe Spasticity

SynchroMed(TM) II for Chronic Pain Is an Alternative to Systemic Opioids for Many Patients

DUBLIN - January 10, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of a new clinician programmer for use with the SynchroMed(TM)II Intrathecal...
Jan 9, 2018

Medtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation Programming

As More Physicians Seek Non-Opioid Treatment Options, the Vectors Study Will Further Advance Understanding of New Approaches to Optimal Spinal Cord Stimulation Treatment

DUBLIN - January 9, 2018 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Vectors Post Market Clinical Study. The study will follow patients with chronic intractable...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa